BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6453906)

  • 1. Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus UVA radiation.
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1981 Jun; 76(6):445-8. PubMed ID: 6453906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms.
    Kripke ML
    Natl Cancer Inst Monogr; 1984 Dec; 66():247-51. PubMed ID: 6531037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and transplantation of murine skin cancers induced by methoxsalen plus ultraviolet (320-400 nm) radiation.
    Kripke ML; Morison WL; Parrish JA
    J Natl Cancer Inst; 1982 Apr; 68(4):685-90. PubMed ID: 7040768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
    Granstein RD; Morison WL; Kripke ML
    Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-susceptibility generated in mice treated with subcarcinogenic doses of 8-methoxypsoralen and long-wave ultraviolet light.
    Roberts LK; Schmitt M; Daynes RA
    J Invest Dermatol; 1979 Jun; 72(6):306-9. PubMed ID: 448163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA).
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1983 Aug; 81(2):87-92. PubMed ID: 6223958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Langerhans cells and Thy-1+ dendritic epidermal cells in murine epidermis during the evolution of ultraviolet radiation-induced skin cancers.
    Alcalay J; Craig JN; Kripke ML
    Cancer Res; 1989 Aug; 49(16):4591-6. PubMed ID: 2568173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA).
    Bruze M; Forsgren A; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):25-30. PubMed ID: 2578702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair elicited by UVB during PUVA therapy for psoriasis.
    Bishop SC; Abel EA
    Arch Dermatol Res; 1985; 278(1):25-30. PubMed ID: 4096527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PUVA and UVB radiation on delayed hypersensitivity in the guinea pig.
    Morison WL; Parrish JA; Woehler ME; Krugler JI; Bloch KJ
    J Invest Dermatol; 1981 Jun; 76(6):484-8. PubMed ID: 6165782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
    Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical UV exposures and HIV activation.
    Zmudzka BZ; Miller SA; Jacobs ME; Beer JZ
    Photochem Photobiol; 1996 Aug; 64(2):246-53. PubMed ID: 8760563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells.
    Aubin F; Donawho CK; Kripke ML
    Cancer Res; 1991 Nov; 51(21):5893-7. PubMed ID: 1933857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology and photocarcinogenesis. New light on an old problem.
    Kripke ML
    J Am Acad Dermatol; 1986 Jan; 14(1):149-55. PubMed ID: 2936770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of psoralens and ultraviolet radiation on murine dendritic epidermal cells.
    Alcalay J; Bucana C; Kripke ML
    J Invest Dermatol; 1989 May; 92(5):657-62. PubMed ID: 2565931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do oral carotenoids protect human skin against ultraviolet erythema, psoralen phototoxicity, and ultraviolet-induced DNA damage?
    Wolf C; Steiner A; Hönigsmann H
    J Invest Dermatol; 1988 Jan; 90(1):55-7. PubMed ID: 3335790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice.
    Talve L; Stenbäck F; Jansén CT
    Photodermatol Photoimmunol Photomed; 1990 Jun; 7(3):109-15. PubMed ID: 2081116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.